Nurhalifah, Prayoga Daffa Sundawan, Santika Citra Veronita, Shella Imka Puji Destria, Siti
Nuryamah, Nia Yuniarsih / JOSR: Journal of Social Research, 2(1), 126-133
Literature Review Article: Drug Delivery System Held in the Stomach
(Gastroretentive) 128
INTRODUCTION
Medicine is an ingredient that aims to be used in determining diagnosis, preventing,
reducing, and curing diseases or symptoms of diseases, wounds, or abnormalities of the
body and spiritually in humans or animals, improving the body or parts of the human body
(Wardani, 2021).
According to (Martien et al., 2012) medicine is a substance that through its
chemical effects brings changes in biological functions. Drug molecules interact with
special molecules in biological systems that act as regulators in this case receptors. To
chemically interact with its receptors, the drug molecule must have the appropriate size,
shape of the electric charge, and atomic composition. Currently, many considerations
underlie the development of technology for pharmaceutical therapy consisting of three
main factors, namely effectiveness, suppressing the effects of harm on the system if applied
(safety), and acceptability to patients (acceptability).
In the process of discovering new pharmaceuticals, pharmaceutical preparation
formulation technology and drug delivery systems played an important role. The main
factors that are generally considered in this field include molecular and physicochemical
considerations such as molecular equilibrium, hydrophilic-lipophilic equilibrium,
biopharmaceutical processes, metabolism and biodegradation, drug-receptor affinity,
physiological considerations, and biocompatibility (Martien et al., 2012). This delivery
system serves to direct the drug molecules to the desired target. This encourages the
development of drug delivery systems, especially in terms of formulations to optimize the
use of additives to obtain a drug preparation with a good delivery system and meet the
therapeutic effect.
The oral drug delivery route is the most preferred because it is easy to use.
Absorption of oral drugs mostly occurs in the stomach and the intestines. Imperfect
absorption in the stomach is caused by the Gastro Residence Time (GRT) factor. The
presence of gastric emptying time causes the drug to not be in the stomach for a long time
so it is necessary to increase GRT. The longer the drug stays in the stomach, the more
absorption of the drug so that the bioavailability of the drug also increases. Therefore, it is
necessary to have a drug delivery system that can extend the contact time with the stomach,
namely the Gastroretentive Drug Delivery System (GRDDS). There have been many
studies on GRDDS formulations, including Nifedipine and Nilotinib formulations to
increase bioavailability, antibiotics to increase the effectiveness of drugs against H. pylori
treatment, ofloxacin as a delayed release drug delivery system, increasing the solubility of
verapamil drugs, furosemide, propranolol, and others (Annisa, n.d.-a).
The GRDDS delivery system is a sustained drug delivery system that can hold
drugs back in the stomach for a longer time. The advantages of GRDDS include being able
to increase bioavailability, increase the solubility of drugs that are poorly soluble in high
pH, can control of therapeutic levels to reduce the occurrence of fluctuations, can extend
the half-life so that the frequency of drug administration can be reduced. However, this
system is not suitable for use in drugs that irritate the stomach, are unstable in gastric pH,
or experience significant first-pass effects. There are several systems in the GRDDS
formulation, namely floating, aggressive, high density, superiors, expandable, raft forming,
and magnetic (Annisa, n.d.-b). This study aims to describe the types of GRDDS
preparations. The variation is due to a combination of differences in mechanisms and
technology.